VentureWell
This spring, VentureWell Senior Program Officer for Health Commercialization Brenna O’Riordan had the opportunity to spotlight two VentureWell Accelerator alumni companies and one of the…
Some innovations are so groundbreaking that the excitement around them can hinder their path to commercialization. When an innovation sounds too good to be true,…
As the Commercialization Center, VentureWell provided infrastructure support for a life-saving hepatitis C test-to-treat breakthrough.
LymeAlert, which recently completed the VentureWell-led National Institutes of Health (NIH) Entrepreneurship Bootcamp, created a kit to help people identify whether a tick carries Lyme-causing bacteria—right at home.
Jason Kang, co-founder of Aspire alumnus Kinnos, shares advice for other early-stage founders.
Max Derbyshire, COO of Acorn Genetics, shares how the E-Team Program and the Aspire investor-engagement program advanced his innovation.
Hear from Ana Cornell about her E-Team Acorn Genetics, which is developing a low-cost, at-home DNA testing kit that enables users to privately test for genetic conditions.
Hear from Heather Holman about her E-Team Heartbeat Technologies, which is working to treat patients experiencing cardiac arrest by increasing blood flow to the heart.
Christina Tamer offers guidance on how early-stage startups can avoid making business and ethical mistakes.
Eric Richardson of Duke University launched a biomedical engineering and entrepreneurship program to help guide students to become healthcare innovators.
TJ Falohun of Ai-Ris is using artificial intelligence to help prevent vision loss in vulnerable and underresourced communities.
Learn how early-stage support helped E-Team HandHero helped transform a scientist’s career trajectory.
Chante’ Knox of E-Team DelivHer FemCare attributes early-stage support for fast-tracking her innovative menstrual care product.
Lura Health has created biosensor technology placed on a tooth to aid in preventive health care, delivering real-time updates through a mobile app.
E-Team Glyscend Therapeutics credits early-stage support for building a foundation that allowed the team to develop a pill mimicking gastric bypass surgery that will revolutionize treatment for type 2 diabetes.
In honor of National Inventors’ Day, we’re recognizing teams working to increase COVID-19 testing capacity.
In honor of our 25th anniversary, we’re honoring the heroes of innovation and entrepreneurship working to build a better world.
VentureWell E-Team, Ateios, is developing a platform technology to manufacture customizable, flexible batteries for the growing medical patches market.
E-Team Neurotendo developed a game-inspired device that enables safer and quicker aneurysm treatment with higher success rates.
E-Team grantee, Adria Abella Villafranca of hDrop developed a wearable device that analyzes dehydration levels and alerts users when it’s necessary to drink water.
First Name
Last Name
Your email
Yes I would like receive weekly newsletters from VentureWell
I'd best describe myself as a: StudentStartupFaculty MemberResearcherOther
By continuing to use the site, you agree to the use of cookies. Read MoreAccept